Funded Research

Analysis of nuclear and cytoplasmic Mcl-1 protein complexes

Year

2004

Host institution

University of British Columbia

Research location

Vancouver Hospital & Health Sciences Centre

Partner

Supervisor

CO-lEad

Tissues in multi-cellular organisms maintain a state of equilibrium (homeostasis) through a delicate balance between controlled cell growth and programmed cell death (apoptosis). Programmed cell death is required to remove superfluous, damaged or harmful cells. Uncontrolled cell growth can lead to cancer, autoimmune disorders and neurodegenerative diseases. The BCL-2 family of proteins tightly regulates the cell death process. Dr. Marc Germain is investigating their role in cell death. One of these proteins, Mcl-1, prevents cell death and also seems to have a role in controlling cell division. Dr. Germain is examining how different forms of this protein control the body’s equilibrium, which could improve understanding of how cancer develops and potentially lead to new anti-cancer drugs.

Building research careers

Since 2001, we’ve supported over 3,000 BC health researchers to launch programs, drive innovations, and attract millions in new research investment.

View all funded research

Funded research